Navin Fluorine International Limited · NSE:NAVINFLUOR

Navin Fluorine International — Investor Presentation (February 2026)

29 slides from Navin Fluorine International's investor presentation, Feb 10, 2026

  1. Slide 1: Intimation of Schedule of Analyst / Institutional Investor Meet

    February 10, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (East), Mumbai 400001 Mumbai 400051 Scrip Code: 532504 Symbol: NAVINFLUOR Dear Sir/Madam, Subject: Intimation of Schedule of Analyst / In

  2. Slide 2: Advancing With Purpose – Investor Presentation February 2026

    Advancing With Purpose Investor Presentation – February 2026

  3. Slide 3: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  4. Slide 4: Q3 & 9M FY26 Financial Performance

    Q3 & 9M FY26 Financial Performance

  5. Slide 5: Q3FY26 - Performance at a glance

    Q3FY26 - Performance at a glance Sales Operating EBITDA Operating EBITDA Margin Operating PBT Rs. 892.4 Crs Rs. 307.6 Crs 34.5% Rs. 243.2 Crs Q3FY26 + 47% Y-o-Y + 109% Y-o-Y + 1017 bps Y-o-Y + 149% Y-o-Y + 18% Q-o-Q + 25% Q-o-Q + 201 bps Q-o-Q + 36% Q-o-Q Revenue Growth (Y-o-Y) HPP Specialty CDMO 35

  6. Slide 6: 9MFY26 - Performance at a glance

    9MFY26 - Performance at a glance Sales Operating EBITDA Operating EBITDA Margin Operating PBT Rs. 2376.2 Crs Rs. 760.5 Crs 32.0% Rs. 563.6 Crs 9MFY26 + 44% Y-o-Y + 114% Y-o-Y + 1047 bps Y-o-Y + 155% Y-o-Y Revenue Growth (Y-o-Y) HPP Specialty CDMO 39% 46% 58% Consolidated Financials 5

  7. Slide 7: 9MFY26 – Sustained Growth

    9MFY26 – Sustained Growth Revenues Operating EBITDA 2,349 2,376 761 534 892 308 725 758 246 207 Q1FY26 Q2FY26 Q3FY26 FY25 9MFY26 Q1FY26 Q2FY26 Q3FY26 FY25 9MFY26 PBT PAT 591 451 380 289 238 185 198 148 155 117 Q1FY26 Q2FY26 Q3FY26 * FY25 9MFY26 * Q1FY26 Q2FY26 Q3FY26* FY25 9MFY26* Rs. crores (* PBT

  8. Slide 8: Ongoing Capex's

    Ongoing Capex's HFC MPP Advanced Materials Additional HFC capacity equivalent upto 15,000 De-bottlenecking MPP capacity at Dahej to Initial commercial capacity for manufacturing to Capex Details MTPA of R32 support launch of new molecule for a global enable adoption of innovative liquid cooling inno

  9. Slide 9: Business Vertical - HPP

    Business Vertical - HPP Revenues Q3FY26 Highlights Rs. crores +35% 412 ✓ Revenue growth led by higher realizations and volumes 306 ✓ Pricing environment for HFC continues to be constructive Q3 FY25 Q3 FY26 ✓ AHF capex : Commissioned in the Q4FY26 with dispatches commenced ✓ Capex for additional HFC

  10. Slide 10: Business Vertical - Specialty Chemicals

    Business Vertical - Specialty Chemicals Revenues Q3FY26 Highlights Rs. crores +60% 354 ✓ Highest ever quarter for Specialty with positive outlook supported by strong order visibility for Q4 and beyond 221 Product pipeline continues to be strong with scale up seen in ✓ the existing molecules and new

  11. Slide 11: Business Vertical - CDMO

    Business Vertical - CDMO Revenues Q3FY26 Highlights Rs. crores +61% 127 ✓ Momentum continues with strong order visibility 79 ✓ European CDMO MSA : • Successful completion of validation, commercial supplies started from cGMP4 Q3 FY25 Q3 FY26 • Strong outlook into CY26 and beyond 6% ✓ Strategy -in-act

  12. Slide 12: Consolidated Profitability Statement

    Consolidated Profitability Statement Y-o-Y Q-o-Q Y-o-Y Particulars (Rs. Crs) Q3 FY26 Q3 FY25 Q2 FY26 9M FY26 9M FY25 Change % Change % Change % Net Revenue From Operations 892.37 606.20 47% 758.42 18% 2,376.19 1,648.44 44% Raw Material 367.72 263.16 312.90 988.33 717.53 Employee Expenses 75.65 71.26

  13. Slide 13: Standalone Profitability Statement

    Standalone Profitability Statement Y-o-Y Q-o-Q Y-o-Y Particulars (Rs. Crs.) Q3 FY26 Q3 FY25 Q2 FY26 9M FY26 9M FY25 Change % Change % Change % Net Revenue From Operations 570.01 439.77 30% 562.37 1% 1,675.33 1,201.87 39% Raw Material 259.53 201.98 251.08 750.05 547.99 Employee Expenses 54.60 52.69 5

  14. Slide 14: Company Overview

    Company Overview

  15. Slide 15: Resilient business model: diversified divisions, products, plants & end markets

    Resilient business model: 3 4 900+ diversified divisions, Geographies Factories Total Customers products, plants & end 4 Countries 3 R&D Centres 1,498 Total Employees markets 3 5 Business Verticals Sales Offices Preferred source and a partner of choice for diverse fluorochemical solutions globally L

  16. Slide 16: 3P approach to building capacities, platforms and partnerships

    3P approach to building Diverse portfolio including fluorine- capacities, building scalable based intermediates, specialty chemicals and inorganic chemicals platforms and nurturing long- term partnerships Product 3P FOCUS Forging multiyear partnerships to Partnerships Focus on owning specific integr

  17. Slide 17: Trusted to deliver, where IP integrity meets excellence and performance

    Trusted to deliver, where IP Robust R&D engagement supports integrity meets excellence and Strong partnership with Global co-development initiatives, Innovators across diverse accelerating innovation & performance segments customised solutions Agile manufacturing Swift absorption of new infrastructu

  18. Slide 18: Navin Fluorine: Precision in chemistry, purpose in execution

    Navin Fluorine: Precision in One-Stop Fluorine provider, with the Group serving Prominent brand symbolising market Rich experience, with decades of operational chemistry, purpose in diverse customer needs, from gramscale to multi- leadership, service reliability, manufacturing expertise, the Group i

  19. Slide 19: Strong R&D to manage diversified portfolios, from ideation to commercialization

    Strong R&D to manage diversified KEY R&D HIGHLIGHTS FY25 portfolios, from ideation to Driving research-based culture to develop complex KSMs for global pharma and biotech commercialization of molecules innovators Backward integration into high end fluorine Navin Research & Innovation Navin Molecular

  20. Slide 20: Enhancing our agility, resilience and competitiveness

    Enhancing our agility, resilience and competitiveness to foster sustainable progress Reputed Brand Mafron Rich Legacy Integrated Fluorine Strategic Committed to ESG Diversified Portfolio Prominent Clientele Provider Partnerships World-class Credible Strong Global Thriving Workforce Infrastructure Ce

  21. Slide 21: Leading with ESG in Action

    Leading with ESG in Action

  22. Slide 22: Environmentally friendly initiatives across our facilities in FY25

    We undertook various environmentally friendly initiatives across our facilities in FY25 SURAT DEWAS DAHEJ • Reduction of 1,66,352 SCM of natural gas using waste heat from flue gas in the HF plant • Increased solar electricity capacity from 1 MW • Condensate recovery from CPP, MEE, Orchid, to 2.2 MW

  23. Slide 23: Progress and impact of our environmental initiatives

    Progress and impact of our environmental initiatives All three sites of Navin Fluorine conferred with 8th Annual HSE Strategy Summit & Awards 2025 for 'Commitment to Environmental Excellence Greentech PCWR Excellence - 2024 Award for Pollution We are a Responsible Care Control, Waste Management & Re

  24. Slide 24: Board Demographics and Independence

    Board Demographics Meetings Board Independence during Highly FY 2025 engaged 6 of 10 Board 15 60% Directors are actively involved in NFIL’s Board Committee Independent strategic transformation 58 years median Directors’ age 8 Highly Experienced Board Board to chair Committees 80% 8 of 10 Directors a

  25. Slide 25: Reflects the practices, regulations and protocols set by our board

    Reflects the practices, regulations and Composition of the Statutory protocols set by our board of directors Committees as on December 31, 2025 Structured policies and processes addressed Out of 4 Members of the Audit Committee, 3 investor grievances are Independent and 1 Non-Executive Reported NO A

  26. Slide 26: Diversity of thought and experience

    Diversity of thought and experience Mr. Vishad P. Mafatlal (Chairman) Ms. Apurva S. Purohit (Independent Director) He is an industrialist having varied experience of over 28+ Years in the field of Textiles and Chemicals. He She is a prominent Indian Business leader with over 32 years of experience i

  27. Slide 27: Investing in community well-being

    Investing in community well-being CSR contribution made to: SHRI SADGURU SEVA ACT-EVE FOUNDATION SANGH TRUST Total CSR expenditure for FY25 Rs. 7.95 Crores CHARUTAR AROGYA MANDAL SHALA PRAVESHOTSAV BLIND PEOPLE’S CANCER PATIENT AID ASSOCIATION ASSOCIATION FOUNDATION FOR KC MAHINDRA PROMOTION OF SPOR

  28. Slide 28: Track record of progressive dividends

    Track record of progressive dividends Dividend as % of Face Value Special Final Interim Payout %* 750% 750% 150% 600% 600% 550% 550% 550% 500% 150% 600% 150% 390% 350% 350% 350% 300% 300% 315% 325% 75% 200% 180% 210% 160% 160% 400% 140% 150% 150% 130% 110% 85% 65% 75% 85% 85% 250% 250% 250% 250% 250

  29. Slide 29: For further information, please contact

    For further information, please contact: Navin Fluorine International Ltd. CIN : L24110MH1998PLC115499 Mr. Anish Ganatra Chief Financial Officer anish.ganatra@nfil.in anish.ganatra@nfil.in www.nfil.in www.nfil.in Investor Relations Advisors: MUFG Intime India Private Limited A part of MUFG Corporate

Navin Fluorine International — Investor Presentation (February 2026) on 6ix